Upneeq is the only FDA-approved once-daily prescription eyedrop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes
UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a prescription eyedrop used to treat acquired blepharoptosis (low-lying lids) in adults.
Actual patient images courtesy of Dr. Robert Schwarcz and Dr. Raymond Douglas. Individual results may vary. The average lift seen in clinical trials was 1 mm.
The most common adverse reactions with UPNEEQ (occurring in 1-5% of patients) were eye inflammation, eye redness, dry eye, blurred vision, eye pain at time of use, eye irritation, and headache.
These are not all of the possible side effects of UPNEEQ. Tell your doctor if you have any side effect that bothers you or does not go away. Call your doctor for medical advice about side effects.
To report side effects or product complaints, contact RVL Pharmaceuticals at 1-877-482-3788. You may also report side effects to the FDA by calling 1-800-FDA-1088 or visit www.fda.gov/medwatch.
This is a summary of the most important safety information for UPNEEQ. For more in-depth safety information, please review the full Prescribing Information for UPNEEQ.
Your health and safety are always our #1 priority. Here is what we are doing to keep you and our team members safe at Back to 30:
We’ve missed you! Call us at 864-372-3003 to schedule your next appointment today.
Thank you for your understanding. Our clients and team members safety and well-being are our top concern.
Back to 30 Team